Trials / Conditions / Edematous Fibrosclerotic Panniculopathy

Edematous Fibrosclerotic Panniculopathy

11 registered clinical trials studyying Edematous Fibrosclerotic Panniculopathy.

Status	Trial	Sponsor	Phase
Completed	Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks NCT05419505	Endo Pharmaceuticals	Phase 2
Completed	Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity NCT05249257	Endo Pharmaceuticals	—
Completed	CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injectio NCT04580303	Endo Pharmaceuticals	Phase 2
Completed	Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH) NCT04381117	Endo Pharmaceuticals	—
Completed	Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women NCT03893890	Endo Pharmaceuticals	—
Completed	Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP NCT03675685	Endo Pharmaceuticals	Phase 1
Completed	Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite) NCT03526549	Endo Pharmaceuticals	Phase 3
Completed	Safety and Effectiveness of EN3835 in the Treatment of EFP in Women NCT03329989	Endo Pharmaceuticals	Phase 2
Completed	EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) NCT02942160	Endo Pharmaceuticals	Phase 2
Completed	EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) NCT02724644	Endo Pharmaceuticals	Phase 2
Completed	The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Pannic NCT01518907	Endo Pharmaceuticals	Phase 1